| Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes DW Kim, KJ Tu, A Wei, AJ Lau, A Gonzalez-Gil, T Cao, K Braunstein, ... Molecular neurodegeneration 17 (1), 83, 2022 | 23 | 2022 |
| 3-Bromopyruvate inhibits pancreatic tumor growth by stalling glycolysis, and dismantling mitochondria in a syngeneic mouse model S Roy, T Dukic, B Bhandary, KJ Tu, J Molitoris, YH Ko, HD Shukla American Journal of Cancer Research 12 (11), 4977, 2022 | 9 | 2022 |
| The impact of telehealth in sepsis care: A systematic review KJ Tu, C Wymore, N Tchangalova, BM Fuller, NM Mohr Journal of telemedicine and telecare, 1357633X231170038, 2023 | 4 | 2023 |
| Dysregulated epigenetics of chordoma: Prognostic markers and therapeutic targets K Tu, S Lee, S Roy, A Sawant, H Shukla Current Cancer Drug Targets 22 (8), 678-690, 2022 | 4 | 2022 |
| Using memes to promote student engagement and classroom community during remote learning K Tu, A Sun, DM Levin Biochemistry and Molecular Biology Education 51 (2), 202-205, 2023 | 3 | 2023 |
| Pooled genetic screens to identify vulnerabilities in TERT-promoter-mutant glioblastoma KJ Tu, CE Stewart, PG Hendrickson, JA Regal, SY Kim, DM Ashley, ... Oncogene 42 (44), 3274-3286, 2023 | 2 | 2023 |
| Therapeutic efficacy of variable biological effectiveness of proton therapy in U-CH2 and MUG-Chor1 human chordoma cell death P Singh, J Eley, N Mahmood, B Bhandary, T Dukic, KJ Tu, J Polf, ... Cancers 13 (23), 6115, 2021 | 2 | 2021 |
| A bioinformatic pipeline for identifying change-of-metabolic-function cancer mutations KJ Tu, BH Diplas, JA Regal, MS Waitkus, CJ Pirozzi, ZJ Reitman Cancer Research 83 (7_Supplement), 3143-3143, 2023 | 1 | 2023 |
| 3-Bromopyruvate in combination with radiation inhibits pancreatic cancer growth by dismantling mitochondria and ATP generation in a preclinical mouse model SK Roy, T Dukic, B Bhandary, A Acharya, KJ Tu, YH Ko, HD Shukla Cancer Research 82 (12_Supplement), 5243-5243, 2022 | 1 | 2022 |
| Amyloid-beta and tau pathologies are both necessary to induce novel stage-specific microglia subtypes during Alzheimer’s disease progression DW Kim, K Tu, A Wei, A Lau, A Gonzalez-Gil, T Cao, K Braunstein, ... bioRxiv, 2021.10. 16.464454, 2021 | 1 | 2021 |
| Docetaxel radiosensitizes castration-resistant prostate cancer by downregulating CAV-1 KJ Tu, SK Roy, Z Keepers, MR Gartia, HD Shukla, NC Biswal International Journal of Radiation Biology 100 (2), 256-267, 2024 | | 2024 |
| Single-fraction Radiation Treatment Dose Response in a Genetically Engineered Mouse Model of Medulloblastoma KJ Tu, CE Stewart, NT Williams, Y Ma, L Luo, D Ghosh, ... Radiation Research 200 (6), 587-592, 2023 | | 2023 |
| Mining cancer genomes for change-of-metabolic-function mutations KJ Tu, BH Diplas, JA Regal, MS Waitkus, CJ Pirozzi, ZJ Reitman Communications Biology 6 (1), 1143, 2023 | | 2023 |
| The use of telehealth in sepsis care: a scoping and systematic review and meta-analysis KJ Tu, C Wymore, N Tchangalova, B Fuller, NM Mohr | | 2023 |
| Telehealth in Sepsis Care: A Scoping Review and Meta-analysis KJ Tu, C Wymore, N Tchangalova, B Fuller, NM Mohr B44. FRAILTY, NUTRITION, AND PROLONGED MECHANICAL VENTILATION, A3407-A3407, 2023 | | 2023 |
| HIF1α is involved in radiation-induced DNA damage repair and anti-apoptotic pathways in pancreatic ductal adenocarcinoma KJ Tu, SK Roy, A Sawant, HD Shukla Cancer Research 83 (7_Supplement), 4810-4810, 2023 | | 2023 |
| Gene expression profile analysis of hyperthermia-induced radiosensitivity in breast cancer KJ Tu, H Zhang, D Rodrigues, JK Molitoris, A Sawant, HD Shukla Cancer Research 83 (7_Supplement), 1104-1104, 2023 | | 2023 |
| A Sweet Method of Modeling Restriction Endonuclease-Based Molecular Cloning K Tu, A Sun, D Levin The American Biology Teacher 85 (1), 52-54, 2023 | | 2023 |
| Abstract PO-126: Loss of HIF1A decreases resistance to radiation and invasiveness in pancreatic ductal adenocarcinoma KJ Tu, SK Roy, B Bhandary, A Sawant, HD Shukla Cancer Research 81 (22_Supplement), PO-126-PO-126, 2021 | | 2021 |
| Loss of HIF1A decreases resistance to radiation and invasiveness in pancreatic ductal adenocarcinoma. KJ Tu, SK Roy, B Bhandary, A Sawant, HD Shukla CANCER RESEARCH 81 (22), 87-87, 2021 | | 2021 |
Hem D ShuklaThe Johns Hopkins University School of Medicine在 jhmi.edu 的电子邮件经过验证
